Pharmaceutical Licenses: Valuation and Execution: A Practical Guide (Pharma, Biotechnology and Bioscience: Science, Technology and Business) Book

The purpose of this book is to provide the reader with clear practical guidance on the process of valuing life sciences technology and the steps involved in successfully realising value through productive mutually-beneficial pharmaceutical licensing transactions. Pharmaceutical companies are increasingly pursuing externally oriented R&D strategies in order to generate robust and diverse clinical development pipelines capable of delivering innovative new treatments. Partnerships with biotechnology companies and academic research institutions are important ways for pharmaceutical companies to access novel therapies and best-in-class capabilities therefore technology licensing represents an integral component of pharmaceutical business strategy.This book describes the key aspects of valuing and licensing life science technology and includes examination of licensing trends and practices across the life sciences industries; descriptions of the various methodologies for valuation of life sciences technology - including the authors' own research in this area; an overview of the different agreement types and deal structures used in pharmaceutical licensing; and finally consideration of the post-signature alliance management aspects of life sciences technology transactions (see contents list for a detailed description of topics covered). This book offers clear practical guidance on the steps involved in determining the value of life sciences technology and the options for realising the value through licensing/partnering. It demystifies the process of life sciences technology valuation. It includes expert case studies written by leading practitioners with unique insights based on real transactions. It provides novel tools templates solutions methodologies and models for readers/practitioners to put directly into use.Read More